Landscapes / Companies
Emergent BioSolutions not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
Drugs
2
in active trials · 31 in all
Trials
2 active
36 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 31 Jul 2028Phase 4 trial completes | |||
| Next date | 31 Jul 2028 · Phase 4 trial completes | ||||
| Also tested for | Botulism | ||||
| Open drug page | |||||
Monoclonal antibody |
Approved | May 2035Phase 4 trial completes | |||
| How it works | An antibody | ||||
| Next date | May 2035 · Phase 4 trial completes | ||||
| Also tested for | Infections, Bacterial | ||||
| Open drug page | |||||
About
- No active trial
- 29 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021